Pre-validated medical packaging

Pro-Tech Design carries a host of pre-validated pouches and trays that are stocked and can get you to market quickly with lower costs. These materials have been tested on our equipment with aging studies for up to 5 years.

Our components are made from premium materials and can be used in various combinations to form single and dual sterile barriers.  Combine with stock labels and secondary packaging for a total packaging solution.

Our customers benefit from:

  • Reduction in Start-Up and Validation Costs
  • Improved Time to Market
  • Increased Buying Power
  • Risk Mitigation – Validated Across Multiple Production Lines and Locations

Please Contact Us today to answer any questions about our pre-validated medical packaging solutions.

Customer case studies

Cost-effective solutions for tight deadines 

ProTech Design specializes in medical device assembly and packaging. We work with you to develop packaging and assembly solutions that meet your quality requirements and budget. We use stock materials and customer design elements to develop the package.

Situation

A customer designed a catheter kit with small accessories.

The customer did not have time to develop custom packaging, had a very tight timeline for a product launch, and needed guidance for medical device sterilization requirements.

Action

Pro-Tech Design used stock pouches, leveraging existing validations to establish a sterile barrier and shelf life for the catheter.

The packaging design used a customer backer card to secure the catheter and components inside the stock pouch.

Our validation experts recommended sterilizing by EO and developed an adoption protocol into Pro-Tech Design’s existing cycle to save cost and time to market.

Results

Development and validation activities were successfully completed within eight weeks.

The customer met their deadline, on a budget, with 100% quality, leading to a successful product launch. Pro-Tech Design’s multiple facilities and redundant equipment helped ensure a smooth transition from clinical samples to full market scale up.